Shanghai Haohai Biological Technology Co (SHSE:688366) FCF Yield %: -3.31 (As of Jun. 30, 2026)


SHSE:688366 Shanghai Haohai Biological Technology Co Ltd SHSE:688366
69 GF Score
Price ¥28.87
GF Value ¥43.53
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shanghai Haohai Biological Technology Co FCF Yield %?

Shanghai Haohai Biological Technology Co SHSE:688366 -2.99% 69 FCF Yield % is -3.31 as of Jun. 30, 2026. GuruFocus rates SHSE:688366 with a GF Score™ of 69/100 and a GF Value™ of ¥43.53 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 1,415 Biotechnology companies, Shanghai Haohai Biological Technology Co ranks better than 69.96% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Shanghai Haohai Biological Technology Co's Trailing 12-Month Free Cash Flow is ¥-196 Mil, and Market Cap is ¥5,944 Mil. Therefore, Shanghai Haohai Biological Technology Co's FCF Yield % for today is -3.31%.

The historical rank and industry rank for Shanghai Haohai Biological Technology Co's FCF Yield % or its related term are showing as below:

SHSE:688366' s FCF Yield % Range Over the Past 10 Years
Min: -6.27   Med: -3.26   Max: 3.67
Current: -3.31


During the past 12 years, the highest FCF Yield % of Shanghai Haohai Biological Technology Co was 3.67%. The lowest was -6.27%. And the median was -3.26%.

SHSE:688366's FCF Yield % is ranked better than
69.96% of 1415 companies
in the Biotechnology industry
Industry Median: -9.49 vs SHSE:688366: -3.31

Shanghai Haohai Biological Technology Co's FCF Margin % for the quarter that ended in Mar. 2026 was -16.97%.


Shanghai Haohai Biological Technology Co FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Shanghai Haohai Biological Technology Co FCF Yield % Related Terms


Shanghai Haohai Biological Technology Co FCF Yield % Historical Data

* Premium members only.

The historical data trend for Shanghai Haohai Biological Technology Co's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Haohai Biological Technology Co FCF Yield % Chart

Shanghai Haohai Biological Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.32 -0.51 1.98 2.04 3.06

Shanghai Haohai Biological Technology Co Quarterly Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.39 0.00 -1.60 -2.09 -4.43

SHSE:688366 vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, Shanghai Haohai Biological Technology Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Haohai Biological Technology Co FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Haohai Biological Technology Co's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Shanghai Haohai Biological Technology Co's FCF Yield % falls into.


SHSE:688366
69GF Score
Shanghai Haohai Biological Technology Co Ltd SHSE:688366
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Haohai Biological Technology Co FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Shanghai Haohai Biological Technology Co's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=304.035 / 9927.2387
=3.06%

Shanghai Haohai Biological Technology Co's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-96.955 * 4 / 8753.40603
=-4.43%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -3.31 mean?
Shanghai Haohai Biological Technology Co (SHSE:688366) has a FCF Yield % of -3.31 as of Jun. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Shanghai Haohai Biological Technology Co and its competitors. According to the industry distribution chart, Shanghai Haohai Biological Technology Co ranks #425 out of 1415 companies in the Biotechnology industry, placing it in the top 30%.
Is Shanghai Haohai Biological Technology Co's FCF Yield % too high?
Shanghai Haohai Biological Technology Co's current FCF Yield % is -3.31. Based on the distribution chart, Shanghai Haohai Biological Technology Co ranks #425 out of 1415 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Shanghai Haohai Biological Technology Co has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Haohai Biological Technology Co's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai Haohai Biological Technology Co ranks #425 out of 1415 companies for FCF Yield %. This puts Shanghai Haohai Biological Technology Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Shanghai Haohai Biological Technology Co and its competitors. Shanghai Haohai Biological Technology Co's current FCF Yield % is -3.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Haohai Biological Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Haohai Biological Technology Co (SHSE:688366) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥43.53, compared to a current price of ¥28.87 — trading 33.7% below its estimated fair value. The current FCF Yield % is -3.31. Shanghai Haohai Biological Technology Co's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Shanghai Haohai Biological Technology Co (SHSE:688366), the current FCF Yield % is -3.31 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Haohai Biological Technology Co (SHSE:688366) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Haohai Biological Technology Co stock appears to be undervalued. The current stock price of ¥28.87 is trading 33.7% below its estimated GF Value™ of ¥43.53. GuruFocus considers Shanghai Haohai Biological Technology Co to be Significantly Undervalued.

Key valuation signals for SHSE:688366:

  • FCF Yield %: -3.31
  • GF Value™: ¥43.53 vs. price of ¥28.87 (33.7% below fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the SHSE:688366 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Haohai Biological Technology Co Business Description

Other Exchanges 06826:Hong Kong5HB:Germany
Address No. 1386 Hongqiao Road, 23rd Floor, WenGuang Plaza, Changning District, Shanghai, CHN
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to a single operating segment, which is the manufacture and sale of biologicals, medical hyaluronate, and intraocular lenses, research and development of biological engineering and pharmaceutical products, and the provision of related services. Its products are categorized into four types, comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China, which is the key revenue driver, the United States, the United Kingdom, and other countries.
69GF Score

Get the complete analysis for SHSE:688366

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥28.87
Price
¥43.53
GF Value